US 11369692
Materials and methods for treatment of Duchenne Muscular Dystrophy
granted A61KA61K35/28A61K35/34
Quick answer
US patent 11369692 (Materials and methods for treatment of Duchenne Muscular Dystrophy) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K35/28, A61K35/34, A61K38/465, A61K48/005